Evidence map›Paper›PMID 28367517›Full record

ArticleNanoImpact2017

Evaluation of tumorigenic potential of CeO

Todd A Stueckle, Donna C Davidson, Raymond Derk, Tiffany G Kornberg, Diane Schwegler-Berry, Sandra V Pirela, Glen Deloid, Philip Demokritou, Sudjit Luanpitpong, Yon Rojanasakul and 1 more

Abstract read
In one paragraph

Article in NanoImpact, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Micro- and Nanosized Substances Cause Different Autophagy-Related Responses.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Todd A StueckleHELD, National Institute for Occupational Safety and Health, Morgantown WV, 26505; Department of Pharmaceutical Sciences, West Virginia University, Morgantown WV, 26506.
Donna C DavidsonHELD, National Institute for Occupational Safety and Health, Morgantown WV, 26505.
Raymond DerkHELD, National Institute for Occupational Safety and Health, Morgantown WV, 26505.
Tiffany G KornbergHELD, National Institute for Occupational Safety and Health, Morgantown WV, 26505; Department of Pharmaceutical Sciences, West Virginia University, Morgantown WV, 26506.
Diane Schwegler-BerryHELD, National Institute for Occupational Safety and Health, Morgantown WV, 26505.
Sandra V PirelaCenter for Nanotechnology and Nanotoxicology, Harvard T. H. Chan School of Public Health, Boston MA.
Glen DeloidCenter for Nanotechnology and Nanotoxicology, Harvard T. H. Chan School of Public Health, Boston MA.
Philip DemokritouCenter for Nanotechnology and Nanotoxicology, Harvard T. H. Chan School of Public Health, Boston MA.
Sudjit LuanpitpongSiriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Yon RojanasakulDepartment of Pharmaceutical Sciences, West Virginia University, Morgantown WV, 26506.
Liying WangHELD, National Institute for Occupational Safety and Health, Morgantown WV, 26505.

Funding

Training Program in Molecular and Integrative Physiological SciencesT32HL007118 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LU, QUAN · 1985 to 2025
$14.3M
Engineered Nanomaterial Synthesis, Characterization and Method Development Center for Nano-safety ResearchU24ES026946 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEMOKRITOU, PHILIP · 2016 to 2020
$3.8M
Induction of Neoplastic Transformation and Cancer Stem Cells by Carbon NanotubesR01ES022968 · NIEHS · WEST VIRGINIA UNIVERSITY · PI ROJANASAKUL, YON · 2014 to 2019
$1.7M
Nanoparticle Fibrogenicity and Fibroblast Stem-Like CellsR01EB018857 · NIBIB · WEST VIRGINIA UNIVERSITY · PI ROJANASAKUL, YON · 2016 to 2019
$1.3M
Intramural CDC HHS CC999999NHLBI NIH HHS T32 HL007118NIBIB NIH HHS R01 EB018857NIEHS NIH HHS R01 ES022968NIEHS NIH HHS U24 ES026946
6 · The paper itself

Abstract

With rapid development of novel nanotechnologies that incorporate engineered nanomaterials (ENMs) into manufactured products, long-term, low dose ENM exposures in occupational settings is forecasted to occur with potential adverse outcomes to human health. Few ENM human health risk assessment efforts have evaluated tumorigenic potential of ENMs. Two widely used nano-scaled metal oxides (NMOs), cerium oxide (nCeO

Indexed as

iron homeostasisnanomaterialnano-scaled metal oxideneoplastic transformationtumorigenesis

Identifiers

PMID28367517
PMCPMC5372702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.